Literature DB >> 24038072

Characterization of the human kinetic adjustment factor for the health risk assessment of environmental contaminants.

Mathieu Valcke1, Kannan Krishnan.   

Abstract

A default uncertainty factor of 3.16 (√10) is applied to account for interindividual variability in toxicokinetics when performing non-cancer risk assessments. Using relevant human data for specific chemicals, as WHO/IPCS suggests, it is possible to evaluate, and replace when appropriate, this default factor by quantifying chemical-specific adjustment factors for interindividual variability in toxicokinetics (also referred to as the human kinetic adjustment factor, HKAF). The HKAF has been determined based on the distributions of pharmacokinetic parameters (e.g., half-life, area under the curve, maximum blood concentration) in relevant populations. This article focuses on the current state of knowledge of the use of physiologically based algorithms and models in characterizing the HKAF for environmental contaminants. The recent modeling efforts on the computation of HKAF as a function of the characteristics of the population, chemical and its mode of action (dose metrics), as well as exposure scenario of relevance to the assessment are reviewed here. The results of these studies, taken together, suggest the HKAF varies as a function of the sensitive subpopulation and dose metrics of interest, exposure conditions considered (route, duration, and intensity), metabolic pathways involved and theoretical model underlying its computation. The HKAF seldom exceeded the default value of 3.16, except in very young children (i.e., <≈ 3 months) and when the parent compound is the toxic moiety. Overall, from a public health perspective, the current state of knowledge generally suggest that the default uncertainty factor is sufficient to account for human variability in non-cancer risk assessments of environmental contaminants.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  environmental contaminants; exposure conditions; human kinetic adjustment factor (HKAF); interindividual variability; monte Carlo simulations; phase I metabolism; physiologically-based pharmacokinetic (PBPK) modeling; risk assessment; steady-state solutions; toxicokinetics

Mesh:

Substances:

Year:  2013        PMID: 24038072     DOI: 10.1002/jat.2919

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  2 in total

Review 1.  Challenges Associated With Applying Physiologically Based Pharmacokinetic Modeling for Public Health Decision-Making.

Authors:  Yu-Mei Tan; Rachel R Worley; Jeremy A Leonard; Jeffrey W Fisher
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

Review 2.  Diagnosis, monitoring and prevention of exposure-related non-communicable diseases in the living and working environment: DiMoPEx-project is designed to determine the impacts of environmental exposure on human health.

Authors:  Lygia Therese Budnik; Balazs Adam; Maria Albin; Barbara Banelli; Xaver Baur; Fiorella Belpoggi; Claudia Bolognesi; Karin Broberg; Per Gustavsson; Thomas Göen; Axel Fischer; Dorota Jarosinska; Fabiana Manservisi; Richard O'Kennedy; Johan Øvrevik; Elizabet Paunovic; Beate Ritz; Paul T J Scheepers; Vivi Schlünssen; Heidi Schwarzenbach; Per E Schwarze; Orla Sheils; Torben Sigsgaard; Karel Van Damme; Ludwine Casteleyn
Journal:  J Occup Med Toxicol       Date:  2018-02-05       Impact factor: 2.646

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.